首页>
外国专利>
ANTAGONISTS OF CAV2.3 R-TYPE CALCIUM CHANNELS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
ANTAGONISTS OF CAV2.3 R-TYPE CALCIUM CHANNELS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
展开▼
机译:CAV2.3 R型钙离子通道治疗神经退行性疾病的拮抗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention provides Cav2.3 R-type voltage gated calcium channel (coded by the CACNA1E gene) antagonists for the treatment and for use in the treatment of neurodegenerative diseases, in particular Parkinson's disease, and pharmaceutical compositions comprising these Cav2.3 R-type calcium channel antagonists. The invention further provide methods for identifying an antagonist of a Cav2.3 R-type calcium channel and testing a compound for activity as an antagonist of a Cav2.3 R-type calcium channel.
展开▼